Skip to Main Content

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our signal to daydream about weekend plans. Once again, our agenda is exceedingly modest. We hope to catch up on our reading and napping, and hang with one or two short people. And how about you? Anything interesting planned? Midsummer is already here, so enjoy the great outdoors while you can. You could make time for someone special or take up a new hobby. Well, whatever you do, have a grand time, but be safe. Enjoy, and see you soon …

President Trump will sign legislation to reauthorize the Prescription Drug User Fee Act, Regulatory Focus says. The U.S. Senate on Thursday followed the U.S. House and passed a measure to ensure industry fees are paid to the Food and Drug Administration user fee programs for prescription drugs, generic drugs, and medical devices for the next five years, STAT notes. Trump wanted to double industry fees.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • As your STAT colleague observed this ‘Right To Try’ bill “… wouldn’t require drug makers to provide the drugs or ask insurance companies to cover the treatments.” So patients will have the right to try to get a drug companies may not want to supply and no one will pay for. A wonderful campaign promise that is essntially ________ . [Choose your own adjective]

Comments are closed.